Antibiotics for Cat Bite Injuries
(CATBITE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates whether antibiotics taken after a cat bite to the hand or forearm can prevent infection. Researchers compare three approaches: no antibiotics, one-day antibiotics, and five-day antibiotics. The goal is to determine if shorter or no antibiotic treatments are as effective as longer ones. Individuals bitten by a cat on the hand or forearm who haven't taken antibiotics in the last 30 days might qualify for this study. As a Phase 4 trial, it involves an FDA-approved treatment and aims to understand its benefits for more patients.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications. However, if you have taken antibiotics in the past 30 days or are on immunosuppressive drugs, you may not be eligible to participate.
What is the safety track record for these treatments?
Research shows that amoxicillin-clavulanate is often recommended for cat bites to prevent infections. Cat bites can cause deep wounds, which are likely to get infected. Amoxicillin-clavulanate effectively reduces this risk. However, some studies found that people taking amoxicillin-clavulanate experienced slightly more side effects than those taking only amoxicillin. These side effects were not severe and included stomach upset.
For those allergic to penicillin, a combination of ciprofloxacin and clindamycin serves as an alternative. In the past, clindamycin was ineffective against certain bacteria, like Pasteurella multocida, which is common in cat bites. Despite this, the combination remains in use when necessary due to allergies.
In this trial, the treatment has reached a phase that usually indicates it is considered safe for many people. The focus is on finding the best duration for taking these antibiotics, suggesting that most safety concerns are already well understood.12345Why are researchers enthusiastic about this study treatment?
Unlike the standard treatments for cat bite injuries, which often involve extended courses of antibiotics, the trial explores the potential of a shorter regimen. Researchers are particularly interested in whether a one-day course of amoxicillin-clavulanate, which combines an antibiotic with a beta-lactamase inhibitor, can be just as effective as the traditional five-day course. This could mean quicker recovery times and reduced antibiotic exposure, which is crucial in preventing antibiotic resistance. For those with penicillin allergies, the trial also tests a combination of ciprofloxacin and clindamycin, offering alternative options without compromising effectiveness. This approach is promising because it may simplify treatment protocols while maintaining or even improving outcomes.
What evidence suggests that this trial's treatments could be effective for cat bite injuries?
Research shows that amoxicillin-clavulanate is the preferred antibiotic to prevent infections from animal bites, such as cat bites. It stops bacteria from spreading in the body. In this trial, participants will join different treatment arms to evaluate the effectiveness of amoxicillin-clavulanate. One arm will receive the antibiotic for 1 day, another for 5 days, and a placebo arm will serve as a comparison. Previous studies found no major difference in infection rates when using this antibiotic for prevention. Another source suggested that taking amoxicillin-clavulanate for 3-5 days can reduce the risk of infection after a cat bite. This antibiotic is often recommended to prevent infections from bites on the hands or forearms. Overall, evidence supports using amoxicillin-clavulanate to lower the risk of infection after a cat bite.13467
Who Is on the Research Team?
Kevin M Klifto, DO, PharmD
Principal Investigator
University of Missouri-Columbia
Are You a Good Fit for This Trial?
Adults over 18 who've been bitten by a cat on the hand or forearm within the last 24 hours can join this trial. They must speak English and be willing to take medication and attend follow-ups. Excluded are those with active infections, recent antibiotic use, immunodeficiencies, certain chronic diseases, fever above 100.4°F, pregnancy, malnutrition or hypersensitivity to study drugs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either placebo or amoxicillin-clavulanate for 1 or 5 days
Follow-up
Participants are monitored for infection development and adverse effects
Outcome Assessment
Assessment of QuickDASH and HAND-Q scores to evaluate disability and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Amoxicillin/clavulanate
- Placebo (microcrystalline cellulose)
Amoxicillin/clavulanate is already approved in European Union, United States, Canada for the following indications:
- Bacterial infections
- Respiratory tract infections
- Skin and soft tissue infections
- Urinary tract infections
- Lower respiratory tract infections
- Otitis media
- Sinusitis
- Skin and skin structure infections
- Urinary tract infections
- Bacterial infections
- Respiratory tract infections
- Skin and soft tissue infections
- Urinary tract infections
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor